Results 21 to 30 of about 6,483 (201)

The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome

open access: yesActa Dermato-Venereologica, 2019
It is difficult to distinguish erythrodermic mycosis fungoides from Sézary syndrome due to their similar clinical and histological features. The main purpose of this study was to investigate whether microRNA expression profiles in lesional skin could ...
Anne Hald Rittig   +6 more
doaj   +1 more source

Itch in patients with cutaneous T-cell lymphoma as a quality of life indicatorCapsule Summary

open access: yesJAAD International, 2022
Background: Cutaneous T-cell lymphoma (CTCL) is a chronic and progressive disease that has a major impact on quality of life (QoL). Objectives: To describe the impact of the different stages of disease in patients with classical mycosis fungoides ...
Rosanne Ottevanger, MD   +5 more
doaj   +1 more source

Elevated Serum CTACK/CCL27 Levels in CTCL [PDF]

open access: yes, 2006
Bulk ionic composition of the aerosol at Kohnen in January ...
Kagami, Shinji   +6 more
core   +1 more source

Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome

open access: yesActa Dermato-Venereologica, 2019
Tumor cells in cutaneous T-cell lymphoma express limited numbers of chemokine receptors. We investigated the expression patterns of CXCR3, CCR3, CCR4 and CCR10 in mycosis fungoides, Sézary syndrome, lym­phomatoid papulosis and anaplastic large cell ...
Yuki Shono   +8 more
doaj   +1 more source

Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update Micose fungóide e síndrome de Sézary: revisão e atualização clínica, histopatológica e imuno-histoquímica

open access: yesAnais Brasileiros de Dermatologia, 2012
This paper reviews the diagnostic and classificatory concepts of mycosis fungoides and Sézary syndrome in light of the latest normative publications. It describes the great variability of the clinical expression of mycosis fungoides in its early stages ...
Thamy Yamashita   +3 more
doaj   +1 more source

Prevalence of mycosis fungoides and its association with EBV and HTLV-1 in Pakistanian patients [PDF]

open access: yes, 2002
Mycosis fungoides (MF) is an indolent T cell lymphoma that is distinguished from other lymphomas by its initial appearance on the skin. The histologic diagnosis of MF may be difficult because there is significant overlap in the histologic features of ...
Moatter, Tariq   +4 more
core   +1 more source

Vojislav Arnovljević described "Sézary syndrome" ten years before Sézary and Bouvrain [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2016
In 1938 Sezary and Bouvrain reported on a patient with a set of symptoms which later began to carry an eponymous designation “Sezary syndrome.” Ten years previously, Vojislav Arnovljević had described a patient with exactly the same set of ...
Čolović Nataša   +3 more
doaj   +1 more source

Nasal Dysbiosis in Cutaneous T-Cell Lymphoma Is Characterized by Shifts in Relative Abundances of Non-Staphylococcus Bacteria

open access: yesJID Innovations, 2022
The nasal microbiome of patients with cutaneous T-cell lymphoma (CTCL) remains unexplored despite growing evidence connecting nasal bacteria to skin health and disease.
Madeline J. Hooper   +12 more
doaj   +1 more source

Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover [PDF]

open access: yes, 2016
Cutaneous T-cell lymphomas (CTCL) are characterized by the presence of chronically inflamed skin lesions containing malignant T cells. Early disease presents as limited skin patches or plaques and exhibits an indolent behavior.
A Antonelli   +171 more
core   +2 more sources

Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells

open access: yesFrontiers in Oncology, 2021
Sézary syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphomas (CTCL) in which the human Telomerase Reverse Transcriptase (hTERT) gene is re-expressed. Current available treatments do not provide long-term response.
Alain Chebly   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy